- Home
- BDTX vs ZIMV Comparison
BDTX vs ZIMV Comparison
Compare BDTX & ZIMV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- ZIMV
- Stock Information
- Founded
- BDTX 2014
- ZIMV 2021
- Country
- BDTX United States
- ZIMV United States
- Employees
- BDTX N/A
- ZIMV N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BDTX Health Care
- ZIMV Health Care
- Exchange
- BDTX Nasdaq
- ZIMV Nasdaq
- Market Cap
- BDTX 132.5M
- ZIMV 262.9M
- IPO Year
- BDTX 2020
- ZIMV N/A
- Fundamental
- Price
- BDTX $2.95
- ZIMV $8.94
- Analyst Decision
- BDTX Strong Buy
- ZIMV Hold
- Analyst Count
- BDTX 6
- ZIMV 2
- Target Price
- BDTX $14.83
- ZIMV $10.00
- AVG Volume (30 Days)
- BDTX 1.2M
- ZIMV 137.3K
- Earning Date
- BDTX 08-05-2025
- ZIMV 07-31-2025
- Dividend Yield
- BDTX N/A
- ZIMV N/A
- EPS Growth
- BDTX N/A
- ZIMV N/A
- EPS
- BDTX 0.09
- ZIMV N/A
- Revenue
- BDTX $70,000,000.00
- ZIMV $443,551,000.00
- Revenue This Year
- BDTX N/A
- ZIMV $1.96
- Revenue Next Year
- BDTX N/A
- ZIMV $1.95
- P/E Ratio
- BDTX $33.54
- ZIMV N/A
- Revenue Growth
- BDTX N/A
- ZIMV N/A
- 52 Week Low
- BDTX $1.20
- ZIMV $8.15
- 52 Week High
- BDTX $6.75
- ZIMV $22.40
- Technical
- Relative Strength Index (RSI)
- BDTX 71.02
- ZIMV 43.56
- Support Level
- BDTX $2.43
- ZIMV $8.85
- Resistance Level
- BDTX $2.72
- ZIMV $10.26
- Average True Range (ATR)
- BDTX 0.17
- ZIMV 0.43
- MACD
- BDTX 0.03
- ZIMV -0.07
- Stochastic Oscillator
- BDTX 93.85
- ZIMV 11.11
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.